Methylphenidate Can Improve Chorea in
NKX2.1
and
ADCY5
Mutation-positive Patients-A Report of Two Children
Mov Disord Clin Pract
.
2018 Apr 6;5(3):343-345.
doi: 10.1002/mdc3.12608.
eCollection 2018 May-Jun.
Authors
J Tübing
1
2
,
J Bohnenpoll
1
,
J Spiegler
3
,
G Gillessen-Kaesbach
4
,
T Bäumer
1
,
C Max
5
,
J Sperner
6
,
C Klein
5
,
A Münchau
1
Affiliations
1
University of Lübeck, Institute of Neurogenetics, Department of Pediatric and Adult Movement Disorders and Neuropsychiatry 23562, Lübeck DE.
2
University of Lübeck, Department of Neurology 23538, Lübeck DE.
3
University of Lübeck, Department of Pediatrics 23538, Lübeck DE.
4
University of Lübeck, Institute of Human Genetics 23538, Lübeck DE.
5
University of Lübeck, Institute of Neurogenetics 23562, Lübeck DE.
6
Doctor's Practice Specializing in Neuropediatrics and Epileptology Heiligen-Geist-Kamp 4a 23568, Lübeck DE.
PMID:
30800710
PMCID:
PMC6336415
DOI:
10.1002/mdc3.12608
No abstract available
Keywords:
ADCY5; Methylphenidate; NKX2.1; benign hereditary chorea (BHC); chorea.